Évaluation psychocomportementale de l'administration de faible dose de kétamine chez le sujet sain

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neurophysiologie Clinique-clinical Neurophysiology

• Publication date

  2003-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0987-7053(03)00028-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study.

  2002cited by this paper
• What does electrodermal activity tell us about prognosis in the schizophrenia spectrum?

  2002cited by this paper
• An fMRI study of facial emotion processing in patients with schizophrenia.

  2002cited by this paper
• NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans

  2002cited by this paper
• Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors.

  2001cited by this paper
• Sequential Regional Cerebral Blood Flow Brain Scans Using PET with H215O Demonstrate Ketamine Actions in CNS Dynamically

  2001cited by this paper
• Facial affect and affective prosody recognition in first-episode schizophrenia.

  2001cited by this paper
• N-methyl-D-aspartate receptors and information processing: human choice reaction time under a subanaesthetic dose of ketamine.

  2001cited by this paper
• Neural correlates of response inhibition for behavioral regulation in humans assessed by functional magnetic resonance imaging.

  2001cited by this paper
• Ketamine decreased striatal [11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysis

  2000cited by this paper
• Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

  2000cited by this paper
• Serotonin model of schizophrenia: emerging role of glutamate mechanisms.

  2000cited by this paper
• Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

  2000cited by this paper
• The Effects of a Sub-Anaesthetic Dose of Ketamine on Human Selective Attention

  2000cited by this paper
• Ketamine Effects on Eye Movements

  2000cited by this paper
• Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions.

  2000cited by this paper
• [Cognitive and emotional disorders in multiple sclerosis. Can a management strategy be envisioned?].

  2000cited by this paper
• Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

  2000cited by this paper
• Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

  1999cited by this paper
• NMDA-Sensitive Glutamate Antagonism: A Human Model for Psychosis

  1999cited by this paper
• Emotional responding in deficit and non-deficit schizophrenia.

  1999cited by this paper
• Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics

  1999cited by this paper
• Generality and specificity of emotion-recognition deficit in schizophrenic patients with positive and negative symptoms.

  1999cited by this paper
• Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

  1999cited by this paper
• Glutamatergic aspects of schizophrenia

  1999cited by this paper
• Preventive strategies in early psychosis: verging on reality

  1998cited by this paper
• Does Ketamine-Mediated N-methyl-D-aspartate Receptor Antagonism Cause Schizophrenia-like Oculomotor Abnormalities?

  1998cited by this paper
• A study of emotional processing in Parkinson's disease.

  1998cited by this paper
• Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

  1998cited by this paper
• Affect recognition in deficit syndrome schizophrenia.

  1998cited by this paper
• The evolving concept of schizophrenia: from Kraepelin to the present and future.

  1997cited by this paper
• Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

  1997cited by this paper
• Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

  1997cited by this paper
• Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.

  1997cited by this paper
• Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

  1997cited by this paper
• Do schizophrenic patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion?

  1996cited by this paper
• NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

  1996cited by this paper
• Emotional facial imagery, perception, and expression in Parkinson's disease

  1995cited by this paper
• Treatment and diagnostic subtype in facial affect recognition in schizophrenia.

  1995cited by this paper
• Emotional processing in schizophrenia: neurobehavioral probes in relation to psychopathology.

  1995cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Inducing and assessing differentiated emotion-feeling states in the laboratory.

  1993cited by this paper
• Flat affect in schizophrenia does not reflect diminished subjective experience of emotion.

  1993cited by this paper
• Perception of Facial Emotion in Schizophrenic and Right Brain-Damaged Patients

  1993cited by this paper
• Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.

  1992cited by this paper
• Noncompetitive excitatory amino acid receptor antagonists.

  1990cited by this paper
• Facial expression of schizophrenic patients and their interaction partners.

  1989cited by this paper
• Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action

  1988cited by this paper
• Ketamine: behavioral effects of subanesthetic doses.

  1984cited by this paper
• Negative v positive schizophrenia. Definition and validation.

  1982cited by this paper
• Ketamine--its pharmacology and therapeutic uses.

  1982cited by this paper
• The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability.

  1980cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Is the antidepressant effect of ketamine separate from its psychotomimetic effect? A Review of rodent models.

  2024cites this paper
• Acute Effects of Ketamine Infusion on Postoperative Mood Scores in Patients Undergoing Dilation and Curettage: A Randomized Double-Blind Controlled Study

  2021cites this paper
• Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

  2021cites this paper
• Impairment of Executive Functions Associated With Lower D-Serine Serum Levels in Patients With Schizophrenia

  2021cites this paper
• Sensorialité sous kétamine

  2021cites this paper
• Potential mechanisms for phencyclidine/ketamine-induced brain structural alterations and behavioral consequences.

  2019cites this paper
• Impaired facial emotion recognition in a ketamine model of psychosis.

  2012cites this paper
• Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia

  2009cites this paper
• Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

  2009cites this paper
• Effect of risperidone versus haloperidol on emotional responding in schizophrenic patients

  2008cites this paper
• Postoperative Ketamine Administration Decreases Morphine Consumption in Major Abdominal Surgery: A Prospective, Randomized, Double-Blind, Controlled Study

  2008cites this paper
• GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles.

  2008cites this paper
• Activities of the Antipsychotic Drugs Haloperidol and Risperidone on Behavioural Effects Induced by Ketamine in Mice

  2008cites this paper
• Cetamina: aspectos gerais e relação com a esquizofrenia

  2005influential citation
• Dopaminergic Contribution to the Regulation of Emotional Perception

  2005cites this paper
• Ketamine, a general anaesthetic agent and more. A review on its use in and out the clinical setting

  2004cites this paper